These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 2369006)

  • 41. Hepatitis B: available vaccine safe, but underused.
    Stehlin D
    Emerg Med Serv; 1990 Jul; 19(7):45, 70-1, 81. PubMed ID: 10105153
    [No Abstract]   [Full Text] [Related]  

  • 42. Status of hepatitis B screening and vaccine use in facilities for mentally retarded persons.
    Dandoy S; Dandoy JR
    Am J Ment Defic; 1986 Sep; 91(2):184-9. PubMed ID: 2945434
    [TBL] [Abstract][Full Text] [Related]  

  • 43. An Advisory Committee Statement (ACS). National Advisory Committee on Immunization (NACI). Supplementary statement on hepatitis prevention.
    Can Commun Dis Rep; 1997 Sep; 23():1-6. PubMed ID: 9327646
    [No Abstract]   [Full Text] [Related]  

  • 44. Immunogenicity of a recombinant, yeast-derived, anti-hepatitis-B vaccine after alternative dosage and schedule vaccination in Pakistani children.
    Akram DS; Maqbool S; Khan DS; Jafri R; Randhawa S; Valenzuela-Silva C; Lopez-Saura P
    Vaccine; 2005 Dec; 23(50):5792-7. PubMed ID: 16303217
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Hepatitis B vaccination with the plasma-derived Hevac-B Pasteur vaccine. A comparison of 2 populations: hospital personnel and hemodialysis patients].
    Di Giandomenico G; Di Giandomenico FW; Volterrani A
    Minerva Med; 1989 Feb; 80(2):149-51. PubMed ID: 2927706
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [The response to vaccination for hepatitis B in chronic hemodialysis patients and in staff groups exposed to hepatitis B].
    Krogsgaard K; Storgaard J; Løkkegaard NJ; Dinesen B; Daugaard J; Overgaard S; Permin H; Wantzin P; Nielsen JO
    Ugeskr Laeger; 1987 Jan; 149(2):84-6. PubMed ID: 3810975
    [No Abstract]   [Full Text] [Related]  

  • 47. [Combined hepatitis A/B immunization in children and adolescents. Economic evaluation of different immunization methods].
    Smala AM; Szucs TD; Berger K; Windorfer A
    MMW Fortschr Med; 1999 Jun; 141(23):55-6. PubMed ID: 10468485
    [No Abstract]   [Full Text] [Related]  

  • 48. The safety and immunogenicity of a recombinant hepatitis B vaccine in neonates.
    Gunn TR; Bosley A; Woodfield DG
    N Z Med J; 1989 Jan; 102(860):1-3. PubMed ID: 2521527
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Vaccination for viral hepatitis A and B in 1990].
    Degos F
    Gastroenterol Clin Biol; 1990; 14(6-7):521-3. PubMed ID: 2397861
    [No Abstract]   [Full Text] [Related]  

  • 50. Recombinant hepatitis B vaccine.
    Med Lett Drugs Ther; 1986 Dec; 28(728):118-9. PubMed ID: 2946924
    [No Abstract]   [Full Text] [Related]  

  • 51. [Hepatitis B. Whom and how to vaccinate].
    Llamas Urrutia C
    Rev Enferm; 1988; 11(119-120):27-34. PubMed ID: 3187337
    [No Abstract]   [Full Text] [Related]  

  • 52. Cutting corners with hepatitis B vaccination.
    Faed JM
    N Z Med J; 1985 Dec; 98(792):1055. PubMed ID: 3867014
    [No Abstract]   [Full Text] [Related]  

  • 53. [Intracutaneous hepatitis B vaccination].
    van Houte DP; Vroom TM
    Ned Tijdschr Geneeskd; 1985 Jun; 129(26):1237-40. PubMed ID: 4022172
    [No Abstract]   [Full Text] [Related]  

  • 54. Absence of hepatitis B surface antigenemia after vaccination.
    Katkov WN; Ault MJ; Dubin SB
    Arch Pathol Lab Med; 1989 Nov; 113(11):1290. PubMed ID: 2530960
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Prevention of hepatitis B by vaccination].
    Degré M; Siebke JC; Frøland SS
    Tidsskr Nor Laegeforen; 1984 Sep; 104(27):1906-7. PubMed ID: 6515608
    [No Abstract]   [Full Text] [Related]  

  • 56. Compliance of housestaff with a free hepatitis B vaccination program.
    Franson TR; Engbring NH
    Wis Med J; 1986 Jan; 85(1):21-3. PubMed ID: 2937209
    [No Abstract]   [Full Text] [Related]  

  • 57. Mass vaccination against hepatitis B in preschool children: immunogenicity after three reduced doses.
    Milne A; Moyes CD; Waldon J; Pearce NE; Krugman S
    N Z Med J; 1989 Aug; 102(874):429-30. PubMed ID: 2527346
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Viral hepatitis: preventable illnesses].
    Baumgarten R
    Z Arztl Fortbild Qualitatssich; 1998 Dec; 92(10):677-80. PubMed ID: 10028595
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [H-B-VAX II].
    Pol Tyg Lek; 1990 Sep 17-24; 45(38-39):801-4. PubMed ID: 2095552
    [No Abstract]   [Full Text] [Related]  

  • 60. Immune dysfunction in patients not responding to hepatitis B vaccination.
    Kitas GD; Salmon M; Emery P
    Lancet; 1989 Mar; 1(8637):551-2. PubMed ID: 2564077
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.